English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 30, 2025

KFF says 12% of U.S. adults have used GLP-1 drugs as Eli Lilly targets compounding pharmacies

+ Pharmaceuticals
Patient Daily | Apr 30, 2025

Congress votes on resolutions affecting clean air standards

+ Pharmaceuticals
Patient Daily | Apr 30, 2025

CDC updates pneumococcal vaccination guidelines for adults at risk

+ Pharmaceuticals
Patient Daily | Apr 30, 2025

Margaret Goodell elected to National Academy of Sciences for stem cell research contributions

+ Pharmaceuticals
Patient Daily | Apr 29, 2025

Eli Lilly boosts federal lobbying spend as it ups legal pressure on compound pharmacies

+ Pharmaceuticals
Patient Daily | Apr 29, 2025

Marine veteran graduates medical school after overcoming hardships

+ Pharmaceuticals
Patient Daily | Apr 29, 2025

Panorama reveals issues with baby food pouches in new investigation

+ Pharmaceuticals
Patient Daily | Apr 28, 2025

Alliance Pharmacy CEO on FDA compounded tirzepatide block: The data used is not 'enough to say the shortage is really over'

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones

  • « First
  • «
  • …
  • 247
  • 248
  • 249
  • 250
  • 251
  • 252
  • 253
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily